Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

6.84% 7.08% 7.11% 7.63%
Piotroski F-Score
7 6 6 6
ROA
4.36% 4.49% 4.54% 4.60%
ROIC
4.34% 4.42% 4.59% 4.37%
Return on Tangible Assets
40.46% 31.48% 30.89% 36.07%
Average Days of Receivables
56.48 58.13 56.26 57.64
Free Cash Flow per Share
7.07 7.43 7.51 7.78
Free Cash Flow
5,028.00 5,293.00 5,318.00 5,489.00
Other line items

Show all line items

Columns are period end dates